News
The End of GLP-1 Compounding
Federally-registered compounding facilities stopped making tirzepatide on May 22. This transition is significant for patients, and we at PSM think there are four things you should be watching for.
[...]May 27, 2025: Global effort to disrupt darknet marketplaces yields 4,400 pounds of illicit drugs
Operation RapTor led to 270 arrests and the seizure of more than $200 million in currency and digital assets.
[...]Empower Pharmacy’s no good, very bad week
Articles in Endpoints News and the Houston Chronicle raise questions about the regulatory process for 503B compounding facilities.
[...]May 19, 2025: Investigations raise questions about product safety at a Texas compounding company
Exposes in the Houston Chronicle and Endpoints News examined Empower Pharmacy’s safety record. A grand jury indicted a Chinese company and three of its employees for pill press and counterfeit die mold sales.
[...]May 12, 2025: FDA will expand unannounced foreign facility inspections, it says
The FDA wants to ensure that domestic and foreign companies receive the same level of regulatory oversight.
Catch up on research PSM released about medicines imported from unregistered sources.
[...]Prescription Drug Freight Fraud Report, May 2025
What if your blood thinners were made in an unverified location in Colombia? In March 2025, dozens of pharmaceutical shipments entered the U.S. that were manufactured in places no one would expect.
[...]May 4, 2025: New study suggests more adverse events associated with compounded GLP-1s than standard formulations
New research shows a correlation between compounded weight loss and diabetes injectables and increased adverse events. GIlead Sciences is suing another New York City pharmacy that allegedly sold counterfeit HIV medicine.
[...]ALERT: New FDA Warning Letter to www.thesafepills.org
The FDA has issued a warning to the operators of the online pharmacy www.thesafepills.org for illegally selling unapproved and misbranded opioid medications, including tapentadol products marketed as Aspadol and Typendol. These unauthorized drugs, sold without a prescription, pose significant health risks such as overdose, addiction, and even death.
[...]April 28, 2025: SafeChain Solutions executive admits to criminal wire fraud in HIV drug diversion case
One of SafeChain’s three owners pleaded guilty. The company collected secondhand HIV medicines from patients and resold them to licensed U.S. pharmacies, forging paperwork to make them look legitimate.
[...]April 21, 2025: Kentucky doctor pleads guilty after injecting patients with semaglutide from unregistered sources
A Kentucky doctor treated weight loss patients with research chemicals; CBP seized 90,000 alprazolam pills being smuggled into the U.S.
[...]